Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site.

O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Abstract Text:

    pauline n wyrembakPauline N Wyrembak,kerim babaogluKerim Babaoglu,ryan b peltoRyan B Pelto,brian k shoichetBrian K Shoichet,r f prattR F Pratt,

    O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Publishing Authors By Initials

    pn wyrembakPN Wyrembak,k babaogluK Babaoglu,rb peltoRB Pelto,bk shoichetBK Shoichet,rf prattRF Pratt,

    For similar enzymes and coenzymes: enzymes: hydrolases: amidohydrolases: beta-lactamases research abstracts see: enzymes and coenzymes: enzymes: hydrolases: amidohydrolases: beta-lactamases research

    PUBMED ID PMID:

    MEDLINE DATE:

    O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Journal of the American Chemical Society

    VOLUME: 129

    Page Numbers: 9548-9

    Journal Abbreviation: J. Am. Chem. Soc.

    ISSN: 0002-7863

    DAY: 12

    MONTH: 07

    YEAR: 2007

    O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7503056

    O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Keywords Mesh Terms:

    KEYWORDS: beta-Lactamases

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Information

    Substance Name: beta-Lactamases

    Registry Number: EC 3.5.2.6

    Grant and Affiliation Information for O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site.

    AFFILIATION: Department of Chemistry, Wesleyan University, Middletown, Connecticut 06459, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIGMS

    GRANT: GM 63815

    ACRONYM: GM

    MEDLINETA: J Am Chem Soc

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News